FDA conducts inspection at Medo Farms, Corp. in Brooklyn on May 24, 2024

Vid Desai FDA’s Chief Information Officer - Official Website
Vid Desai FDA’s Chief Information Officer - Official Website
0Comments

On May 24, 2024, the Food and Drug Administration conducted an inspection of Medo Farms, Corp. in Brooklyn to assess risks related to foodborne biological hazards, according to data posted on the FDA’s website.

The FDA’s final report concluded that Medo Farms, Corp. was not required to make any changes to its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA conducts May 20 inspection at VMI Trading, Inc. in New York

The Food and Drug Administration inspected VMI Trading, Inc. in New York on May 20, focusing on potential foodborne biological hazards, according to FDA data.

Columbia’s Irving Institute receives $75 million grant for clinical and translational research

Columbia’s Irving Institute receives $75 million grant for clinical and translational research

Columbia University’s Irving Institute has received a $75 million federal grant supporting its biomedical research efforts. The award will fund infrastructure improvements as well as education initiatives aimed at translating scientific discoveries into patient care.

Four early-career physician-scientists named 2026 Gerstner Scholars at Columbia VP&S

Four early-career physician-scientists named 2026 Gerstner Scholars at Columbia VP&S

Four early-career physician-scientists have been named 2026 Gerstner Scholars at Columbia University Vagelos College of Physicians and Surgeons for their innovative translational research projects across multiple medical fields. The program provides multi-year funding and recognizes exceptional progress through its annual Merit Award.